Muloc, Salwa T.

HRN: 27-41-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2025
AMPICILLIN 1GM (VIAL)
07/14/2025
07/21/2025
IVT
2gms
Q6
Thickly Msaf
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: